Mathematical Properties of Incremental Effect Additivity and Other Synergy Theories
Authors:
Leonid Hanin,
Liyang Xie,
Rainer Sachs
Abstract:
Synergy theories for multi-component agent mixtures use 1-agent dose-effect relations, assumed known from analyzing previous 1-agent experiments, to calculate baseline Neither-Synergy-Nor-Antagonism mixture dose-effect relations. The most commonly used synergy theory, Simple Effect Additivity, is not self-consistent mathematically. Many nonlinear alternatives have been suggested, almost all of whi…
▽ More
Synergy theories for multi-component agent mixtures use 1-agent dose-effect relations, assumed known from analyzing previous 1-agent experiments, to calculate baseline Neither-Synergy-Nor-Antagonism mixture dose-effect relations. The most commonly used synergy theory, Simple Effect Additivity, is not self-consistent mathematically. Many nonlinear alternatives have been suggested, almost all of which require an assumption that effects increase monotonically as dose increases. We here emphasize the recently introduced Incremental Effect Additivity synergy theory and briefly discuss Loewe Additivity. By utilizing the fact that, when dose increments approach zero, dose-effect relations approach linearity, Incremental Effect Additivity theory to some extent circumvents the non-linearity of dose-effect relations that plague Simple Effect Additivity calculations. We study mathematical properties of Incremental Effect Additivity that are relevant to practical implementation of this synergy theory and hold whatever particular area of biology, medicine, toxicology or pharmacology is involved. However, as yet Incremental Effect Additivity synergy theory has only been applied to mixture experiments simulating the toxic galactic cosmic ray mixture encountered during voyages in interplanetary space. Our main results are theorems, propositions, examples and counterexamples revealing various properties of Incremental Effect Additivity synergy theory including whether or not Neither-Synergy-Nor-Antagonism dose-effect relations lie between 1-agent dose-effect relations. These results are amply illustrated with figures.
△ Less
Submitted 24 December, 2021;
originally announced December 2021.
Mathematical Discovery of Natural Laws in Biomedical Sciences: A New Methodology
Authors:
Leonid Hanin
Abstract:
As biomedical sciences discover new layers of complexity in the mechanisms of life and disease, mathematical models trying to catch up with these developments become mathematically intractable. As a result, in the grand scheme of things, mathematical models have so far played an auxiliary role in biomedical sciences. We propose a new methodology allowing mathematical modeling to give, in certain c…
▽ More
As biomedical sciences discover new layers of complexity in the mechanisms of life and disease, mathematical models trying to catch up with these developments become mathematically intractable. As a result, in the grand scheme of things, mathematical models have so far played an auxiliary role in biomedical sciences. We propose a new methodology allowing mathematical modeling to give, in certain cases, definitive answers to systemic biomedical questions that elude empirical resolution. Our methodology is based on two ideas: (1) employing mathematical models that are firmly rooted in established biomedical knowledge yet so general that they can account for any, or at least many, biological mechanisms, both known and unknown; (2) finding model parameters whose likelihood-maximizing values are independent of observations (existence of such parameters implies that the model must not meet regularity conditions required for the consistency of maximum likelihood estimator). These universal parameter values may reveal general patterns (that we call natural laws) in biomedical processes. We illustrate this approach with the discovery of a clinically important natural law governing cancer metastasis. Specifically, we found that under minimal, and fairly realistic, mathematical and biomedical assumptions the likelihood-maximizing scenario of metastatic cancer progression in an individual patient is invariably the same: Complete suppression of metastatic growth before primary tumor resection followed by an abrupt growth acceleration after surgery. This scenario is widely observed in clinical practice and supported by a wealth of experimental studies on animals and clinical case reports published over the last 110 years. The above most likely scenario does not preclude other possibilities e.g. metastases may start aggressive growth before primary tumor resection or remain dormant after surgery.
△ Less
Submitted 3 June, 2019;
originally announced June 2019.
